Reply Nathan Nathan12 minutes ago Found this on Twitter :
“NOVN Occupies space at 4105 Hopson Rd, Morrisville, NC at 53K Sq Feet Office Floor. When we google this place a company not just $NOVN occupies it: Introducing Kymanox.
Who is Kymanox: premier professional services organization with a focus on project delivery. Basically, they help small bios move through trials faster and to patients. Hmm.. $NOVN
Now, one of the individuals who lead the Kymanox team is a guy name Ryan Doxey. He is also named on multiple patents with $NOVN! Latest Patents have his name on it with $NOVN Nathan Stakso. THIS IS CALLED CONNECTING THE DOTS.”
And to finish it off...
Ligand Pharmaceuticals has just followed Novan Inc. / As well as $LGND trading at $122/share invested $12M to $NOVN in 2019 to fund SB206 program to earn 7-10% of future sales.”
Monday please come faster 🚀
N
Found this on Twitter :
“NOVN Occupies space at 4105 Hopson Rd, Morrisville, NC at 53K Sq Feet Office Floor. When we google this place a company not just $NOVN occupies it: Introducing Kymanox.
Who is Kymanox: premier professional services organization with a focus on project delivery. Basically, they help small bios move through trials faster and to patients. Hmm.. $NOVN
Now, one of the individuals who lead the Kymanox team is a guy name Ryan Doxey. He is also named on multiple patents with $NOVN! Latest Patents have his name on it with $NOVN Nathan Stakso. THIS IS CALLED CONNECTING THE DOTS.”
And to finish it off...
Ligand Pharmaceuticals has just followed Novan Inc. / As well as $LGND trading at $122/share invested $12M to $NOVN in 2019 to fund SB206 program to earn 7-10% of future sales.”
"We think that the data generated to date shows that the SB206 safely improves molluscum. With sufficient financing to complete the trial and submit an NDA, Novan is an attractive investment." PAYtience... 1Q-2Q 2021, if this SB206 works, We can see 5$ for $NOVN easy.
Novan $NOVN 10 days compliance above 1$. We did it!! @Novan_Biotech lets keep the good work. Anti #covid spray + #molluscum first treatment. Long and strong🤓👏
Why are many bio stocks trending higher. As a stockholder of $ONTX, $NOVN, $TNXP, $LPCN and $ADMP, I’m pleased but skeptical. What is driving this industry trend?
Last week I debated between buying either $ONTX or $NOVN. I chose to buy NOVN, should have went with the other stock, that's usually the way things work out for me :(
Reply Nathan Nathan12 minutes ago Found this on Twitter :
“NOVN Occupies space at 4105 Hopson Rd, Morrisville, NC at 53K Sq Feet Office Floor. When we google this place a company not just $NOVN occupies it: Introducing Kymanox.
Who is Kymanox: premier professional services organization with a focus on project delivery. Basically, they help small bios move through trials faster and to patients. Hmm.. $NOVN
Now, one of the individuals who lead the Kymanox team is a guy name Ryan Doxey. He is also named on multiple patents with $NOVN! Latest Patents have his name on it with $NOVN Nathan Stakso. THIS IS CALLED CONNECTING THE DOTS.”
And to finish it off...
Ligand Pharmaceuticals has just followed Novan Inc. / As well as $LGND trading at $122/share invested $12M to $NOVN in 2019 to fund SB206 program to earn 7-10% of future sales.”
Buy Alert! $NOVN-All indicators pointing out the shares $NOVN will close today at $2.73 USD and will opens Tuesday by $3.12 a share. Next week news coming regarding the FDA approval and registration of the $NOVN patents . We will Remained you that at December 5th 2016 $NOVN was around 30$ a share $NOVN-did not had Corona-19 Virus and Lang caner medication and so many patents $NOVN could jump by 30$ a share on any good news.
$NOVN can help MILLIONS of people treat Molluscum. Can you see the potential here? “Molluscum affects millions of people each year, a large percentage of those patients being children under the age of ten. SB206 represents, what I believe to be, an incredible opportunity to provide patients and caregivers an alternative treatment to the options currently available, including off-label prescriptions, procedures, and over-the-counter treatments with no clinical data"
“We need to get vaccine formats which are much more scalable and distributable, so, whether they are pills or patches or nose sprays, we need to find better ways of developing and delivering vaccines." Kate Bingham, who led the UK Vaccine Tastforce until the end of 2020 $NOVN $VXRT
It keeps coming, $NOVN great work. To the moon! 🚀 $NOVN Novan Announces First Patient Enrolled And Dosed In B-SIMPLE4 Pivotal Phase 3 Study Of SB206 For Treatment Of Molluscum
December 5th 2016 $NOVN was around 30$... we have to go back to that price with good news about molluscum treatment and anti-covid spray. Soon. Jump in now and hold.
$NOVN In case you guys don't know, I live in Boston and we have some of the best hospitals in the world as a fact. MGH is best-ranked hospital in the world behind the children's hospitals in Boston as well. They would not be involved if this is a pump and dump.
$NOVN A quick google search of Cole Ikkala working at Novan shows that the email is legitimate. He works at Novan and has 500+ connections
Reply
Nathan
Nathan12 minutes ago
Found this on Twitter :
“NOVN Occupies space at 4105 Hopson Rd, Morrisville, NC at 53K Sq Feet Office Floor. When we google this place a company not just $NOVN occupies it: Introducing Kymanox.
Who is Kymanox: premier professional services organization with a focus on project delivery. Basically, they help small bios move through trials faster and to patients. Hmm.. $NOVN
Now, one of the individuals who lead the Kymanox team is a guy name Ryan Doxey. He is also named on multiple patents with $NOVN! Latest Patents have his name on it with $NOVN Nathan Stakso. THIS IS CALLED CONNECTING THE DOTS.”
And to finish it off...
Ligand Pharmaceuticals has just followed Novan Inc. / As well as $LGND trading at $122/share invested $12M to $NOVN in 2019 to fund SB206 program to earn 7-10% of future sales.”
Monday please come faster 🚀
“NOVN Occupies space at 4105 Hopson Rd, Morrisville, NC at 53K Sq Feet Office Floor. When we google this place a company not just $NOVN occupies it: Introducing Kymanox.
Who is Kymanox: premier professional services organization with a focus on project delivery. Basically, they help small bios move through trials faster and to patients. Hmm.. $NOVN
Now, one of the individuals who lead the Kymanox team is a guy name Ryan Doxey. He is also named on multiple patents with $NOVN! Latest Patents have his name on it with $NOVN Nathan Stakso. THIS IS CALLED CONNECTING THE DOTS.”
And to finish it off...
Ligand Pharmaceuticals has just followed Novan Inc. / As well as $LGND trading at $122/share invested $12M to $NOVN in 2019 to fund SB206 program to earn 7-10% of future sales.”
Monday please come faster 🚀
https://www.wbrz.com/news/inhaled-nitric-oxide-therapy-could-help-kill-coronavirus-lsu-researcher-says
This stock may surprise more then a few when people see
Triple digit gains Monday or Tuesday $NOVN
$NOVN
Yahoo Price Target $1.50 ...current .54
https://finance.yahoo.com/quote/NOVN?p=NOVN
BOOM BOOM Monday.
Insider Buyer! Cha Ching!
REMINDER FROM LGND BOARD ($125 STOCK)
FROM LGND BOARD
Reply
Nathan
Nathan12 minutes ago
Found this on Twitter :
“NOVN Occupies space at 4105 Hopson Rd, Morrisville, NC at 53K Sq Feet Office Floor. When we google this place a company not just $NOVN occupies it: Introducing Kymanox.
Who is Kymanox: premier professional services organization with a focus on project delivery. Basically, they help small bios move through trials faster and to patients. Hmm.. $NOVN
Now, one of the individuals who lead the Kymanox team is a guy name Ryan Doxey. He is also named on multiple patents with $NOVN! Latest Patents have his name on it with $NOVN Nathan Stakso. THIS IS CALLED CONNECTING THE DOTS.”
And to finish it off...
Ligand Pharmaceuticals has just followed Novan Inc. / As well as $LGND trading at $122/share invested $12M to $NOVN in 2019 to fund SB206 program to earn 7-10% of future sales.”
Monday please come faster 🚀
“Molluscum affects millions of people each year, a large percentage of those patients being children under the age of ten. SB206 represents, what I believe to be, an incredible opportunity to provide patients and caregivers an alternative treatment to the options currently available, including off-label prescriptions, procedures, and over-the-counter treatments with no clinical data"
Happy new years!
$NOVN Novan Announces First Patient Enrolled And Dosed In B-SIMPLE4 Pivotal Phase 3 Study Of SB206 For Treatment Of Molluscum
$NOVN
A quick google search of Cole Ikkala working at Novan shows that the email is legitimate. He works at Novan and has 500+ connections
$NOVN clinicaltrials.gov/ct2/show...
https://alphastocknews.com/novan-novn-stock-rockets-on-nitric-oxide-study/2776/